The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.
The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to AstraZeneca. Immunity to the new coronavirus is uncertain and so the use of vaccines is unclear.
The United States will pump up to $1.2 billion into developing AstraZeneca’s potential COVID-19 vaccine and said on Thursday it would order 300 million doses, as the White House seeks solutions to the coronavirus pandemic.
The commitment provides for a possible U.S.-based clinical trial this summer involving 30,000 volunteers and adds fuel to the British drugmaker’s efforts to develop a vaccine for the disease, one of around 100 which are under way worldwide.
People who recover from COVID-19 but test positive for the virus again days or weeks later are not shedding viral particles and are not infectious, according to data released Tuesday by the Korea Centers for Disease Control and Prevention.
London (CNN)The World Health Organization (WHO) has agreed to hold an inquiry into the global response to the coronavirus pandemic, adopting a resolution a summit that has been overshadowed by President Donald Trump's threat to permanently cut US funding to the agency.
The first hints that a vaccine can train people's immune system to fight coronavirus have been reported by a company in the US.
Moderna said neutralising antibodies were found in the first eight people who took part in their safety trials.
It also said the immune response was similar to people infected with the actual virus.
POTUS says coronavirus tests are ‘overrated,’ while he gets tested daily.
POTUS clearly cares more about HIS numbers than he cares about US people dying.......
“Please discontinue patient testing and return of diagnostic results to patients until proper authorization is obtained,” the FDA told the Seattle Coronavirus Assessment Network (SCAN) in a memo, according to The New York Times.
The Food and Drug Administration is cautioning the public about the reliability of a widely used rapid test for the coronavirus. The test, made by Abbott Laboratories, has been linked with inaccurate results that could falsely reassure patients that they are not infected with the virus.
